コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 brain and spinal cord, as well as aneurysm, subarachnoid and cerebral haemorrhage, carotid dissectio
2 of the model showed severe brain injury with subarachnoid and hemorrhage together with glial cell act
3 as associated with poor clinical grade, more subarachnoid and intraventricular blood seen on admissio
5 venteen neonates with ICHs (16 subdural, two subarachnoid, and six parenchymal hemorrhages) were iden
9 ng of the applicability of the International Subarachnoid Aneurysm Trial data and the roles of surgic
10 Intracranial Aneurysms and the International Subarachnoid Aneurysm Trial have provided data on the na
11 uptured Aneurysm Trial and the International Subarachnoid Aneurysm Trial II, are aimed at improving u
12 hemorrhage developed from the International Subarachnoid Aneurysm Trial in a retrospective unselecte
13 an observed probabilities, the International Subarachnoid Aneurysm Trial prediction model needs to be
14 n continues to emerge from the International Subarachnoid Aneurysm Trial, with a neuropsychological s
16 tin, could inhibit the vasospasm provoked by subarachnoid blood in a rat subarachnoid hemorrhage mode
19 ampled CSF for 6 hours through an indwelling subarachnoid catheter in PTSD patients before, during, a
21 innervation and function that correlate with subarachnoid CN3 hypoplasia, occasional abducens nerve h
22 nd the associated inflammatory milieu in the subarachnoid compartment plays a role in the pathogenesi
25 king transforming growth factor-beta-induced subarachnoid fibrosis and protected against hydrocephali
26 nal fluid flow and drainage is obstructed by subarachnoid fibrosis in which the potent fibrogenic cyt
27 minal aortic aneurysm (0.46 [0.35-0.59]) and subarachnoid haemorrhage (0.48 [0.26-0.89]), and not ass
29 hage (hazard ratio 1.44 [95% CI 1.32-1.58]), subarachnoid haemorrhage (1.43 [1.25-1.63]), and stable
30 egree relative affected (FDRA) by aneurysmal subarachnoid haemorrhage (aSAH) are at a higher lifetime
32 INTRODUCTION: Acute non-traumatic convexity subarachnoid haemorrhage (cSAH) is increasingly recognis
37 hort have reported on the risks of recurrent subarachnoid haemorrhage and death or dependency for a m
38 with confirmatory evidence of an aneurysmal subarachnoid haemorrhage and presenting less than 96 h f
39 of global as opposed to focal deficits after subarachnoid haemorrhage and traumatic brain injury in h
42 e complex treatment strategies applied after subarachnoid haemorrhage call for interdisciplinary coll
43 The management of patients with aneurysmal subarachnoid haemorrhage demands expertise to anticipate
50 ety concerns, we conclude that patients with subarachnoid haemorrhage should not be treated routinely
53 ated ipsilateral basal ganglia bleeding with subarachnoid haemorrhage with no aetiology is uncommon.
54 tudy (cardiac arrest, pneumonia, sepsis, and subarachnoid haemorrhage), none were deemed treatment re
56 ars or older with hypertension, a history of subarachnoid haemorrhage, and a giant-sized (>20 mm) pos
57 schaemia (DCI) which occurs after aneurysmal subarachnoid haemorrhage, and often leads to cerebral in
58 redictors were age, hypertension, history of subarachnoid haemorrhage, aneurysm size, aneurysm locati
59 cal clipping or endovascular coiling after a subarachnoid haemorrhage, assuming treatment equipoise,
60 nts with ischaemic and haemorrhagic strokes, subarachnoid haemorrhage, cerebrovascular malformations,
61 e intensive care management of patients with subarachnoid haemorrhage, emphasizing the detection and
62 atment (one retroperitoneal haemorrhage, one subarachnoid haemorrhage, one respiratory distress, and
63 can present with headache, ischaemic stroke, subarachnoid haemorrhage, or symptoms associated with ma
64 s also a functionally significant feature of subarachnoid haemorrhage, raising the prospect of common
67 human brain injured by trauma or aneurysmal subarachnoid haemorrhage, we used DC electrode recording
73 rebral vasospasm in patients with aneurysmal subarachnoid haemorrhage; (4) the use in the biomechanic
74 n-Hispanic black patients aged 45 to 54 with subarachnoid hemorrhage (13.2/10000 to 10.3/10000 hospit
75 c stroke (19%), 936 ventilated patients with subarachnoid hemorrhage (32%), and 1,404 ventilated pati
76 Of 383 patients enrolled, there were 128 subarachnoid hemorrhage (33.4%), 134 subdural hematoma (
79 and 131 met CT criteria for PM nonaneurysmal subarachnoid hemorrhage (53 women; mean age, 53 years [r
82 al hemorrhage (HR, 1.9; 95% CI, 1.5-2.4) and subarachnoid hemorrhage (HR, 2.4; 95% CI, 1.7-3.5) than
83 (odds ratio [OR], 2.494), the indication of subarachnoid hemorrhage (OR, 2.523), and the comorbidity
84 hemorrhage (RR: 0.96; 95% CI: 0.84, 1.10) or subarachnoid hemorrhage (RR: 1.01; 95% CI: 0.90, 1.14).
88 in acute brain injury but an involvement in subarachnoid hemorrhage (SAH) has not been investigated.
89 mic neurological damage following aneurysmal subarachnoid hemorrhage (SAH) have remained elusive.
95 rospective observational study of aneurysmal subarachnoid hemorrhage (SAH) patients, we explored the
99 ness (LOC) is a common presenting symptom of subarachnoid hemorrhage (SAH) that is presumed to result
101 stoperative ICU management of patients after subarachnoid hemorrhage (SAH), especially with regards t
102 m is usually associated with the presence of subarachnoid hemorrhage (SAH), SAH is not required for v
112 patients: adjusted odds ratios (95% CI) for subarachnoid hemorrhage 0.17 (0.06-0.45) and intracerebr
113 % vs. 32%), and more intracranial pathology (subarachnoid hemorrhage 62% vs. 44%; intraparenchymal le
115 ology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, th
117 protective against early brain injury after subarachnoid hemorrhage and determined whether this effe
118 seizure like activity found to have diffuse subarachnoid hemorrhage and extensive dural venous sinus
119 rebral vasospasm in patients with aneurysmal subarachnoid hemorrhage and for guiding transfusion ther
120 Conclusion In patients with PM nonaneurysmal subarachnoid hemorrhage and initial DSA negative for ane
122 O administered for 8h improved recovery from subarachnoid hemorrhage and reduced the inflammatory res
123 ocity were improved between acute aneurysmal subarachnoid hemorrhage and stable state (p </= .005); c
126 ever is sustained for longer durations after subarachnoid hemorrhage and traumatic brain injury.
127 lactate and glucose levels after aneurysmal subarachnoid hemorrhage are associated with delayed cere
128 chemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage as defined by validated diagnosi
129 2000 to 2013, 252 consecutive patients with subarachnoid hemorrhage at computed tomography (CT) and
131 redict 60-day case fatality after aneurysmal subarachnoid hemorrhage developed from the International
132 rted on a case of a 16-year-old patient with subarachnoid hemorrhage diagnosed due to a ruptured cere
133 dministration of sodium nitrite after severe subarachnoid hemorrhage differentially influences quanti
135 nterventions for intracerebral hemorrhage or subarachnoid hemorrhage generally hinge on whether they
140 common complication in the first week after subarachnoid hemorrhage in severe cases admitted to ICU.
141 e young age and high prevalence of traumatic subarachnoid hemorrhage in this cohort may limit its gen
143 eated with an equal volume (1 microL) of pre-subarachnoid hemorrhage intracerebroventricular administ
145 s primary cerebral vasculitis and aneurysmal subarachnoid hemorrhage is common because of overlapping
146 imal timing of tracheostomy in patients with subarachnoid hemorrhage is controversially debated.
147 that the primary cause of poor outcome after subarachnoid hemorrhage is not only cerebral arterial na
151 ssociated with inferior outcomes, to compare subarachnoid hemorrhage mortality with other neurologica
152 tion with isoflurane in patients with severe subarachnoid hemorrhage not having intracranial hyperten
154 defined as the presence of intracerebral or subarachnoid hemorrhage on computed tomography or magnet
159 ly and particularly to vulnerable regions in subarachnoid hemorrhage patients at risk for delayed cer
160 omparison with other neurological diagnoses, subarachnoid hemorrhage patients had significantly great
161 udy was to describe in-hospital mortality in subarachnoid hemorrhage patients requiring ICU admission
162 lity physiological recordings in 48 comatose subarachnoid hemorrhage patients to better characterize
166 neurological outcome in good-grade surgical subarachnoid hemorrhage patients, as assessed by the Gla
169 time points: on admission (acute aneurysmal subarachnoid hemorrhage phase) and at least 21 days late
170 determinant of outcome with intracranial or subarachnoid hemorrhage predicting a extremely high mort
171 ation rates for intracerebral hemorrhage and subarachnoid hemorrhage remained stable, with the except
172 e polycystic kidney disease, presenting with subarachnoid hemorrhage secondary to a ruptured intracra
175 ncreased due to sympathetic activation after subarachnoid hemorrhage similar to critically ill patien
176 diagnoses, and to explore the variability in subarachnoid hemorrhage standardized mortality ratios.
181 At baseline, the severity of aneurysmal subarachnoid hemorrhage was assessed clinically (Hunt an
183 ng manual PVI (1%), an SCL with asymptomatic subarachnoid hemorrhage was detected; the bleeding compl
187 spital between 2006 and 2011 with poor-grade subarachnoid hemorrhage were prospectively entered into
188 omatose patients with high-grade spontaneous subarachnoid hemorrhage who underwent continuous surface
190 al aneurysm (CA) rupture is a major cause of subarachnoid hemorrhage with high morbidity and mortalit
191 ctive properties of argon after experimental subarachnoid hemorrhage with mortality as the primary en
195 with traumatic brain injury, 10% to 14% with subarachnoid hemorrhage, 1% to 21% with intracerebral he
196 ing and 2) an open-field test 24 hours after subarachnoid hemorrhage, 3) protein analysis of hippocam
197 ange of disorders including ischemic stroke, subarachnoid hemorrhage, and brain trauma, and suggest a
198 ies in patients with traumatic brain injury, subarachnoid hemorrhage, and intracranial hemorrhage hav
203 feasible in patients with intracerebral and subarachnoid hemorrhage, but has yet to be tested in a p
204 (brain infarction, intracerebral hemorrhage, subarachnoid hemorrhage, coronary heart disease and deat
207 luding migraine, ischemic stroke, aneurysmal subarachnoid hemorrhage, intracerebral hematoma, and tra
210 hereas gabapentin/pregabalin were favored in subarachnoid hemorrhage, intracranial hemorrhage, spine,
211 ular outcomes, including ischemic stroke and subarachnoid hemorrhage, leading to long-term physical a
213 ated with poor outcome, but after aneurysmal subarachnoid hemorrhage, this has not been investigated.
214 brain, including traumatic brain injury and subarachnoid hemorrhage, thus improvement in outcome may
215 Urgent surgery patients and patients with a subarachnoid hemorrhage, trauma, acute renal failure, or
216 se in the prevalence of hospitalizations for subarachnoid hemorrhage, whereas females aged 5 to 14 ye
217 ointensive care," "neurological," "stroke," "subarachnoid hemorrhage," "intracerebral hemorrhage," or
218 als were randomly assigned to sham-operated, subarachnoid hemorrhage-vehicle, and subarachnoid hemorr
251 % vs 28.2%, p<0.001), with larger amounts of subarachnoid (Hijdra Sum Score 17 vs 14, p<0.001) and in
254 g (PSCO)-and the anterior-most aspect of the subarachnoid space (ASAS), within digital three-dimensio
255 d increased cerebrospinal fluid (CSF) in the subarachnoid space (i.e., extra-axial CSF) from 6 to 24
257 ted CD4(+) T cells gain direct access to the subarachnoid space and become reactivated on encounter w
258 mphatic vessels absorb CSF from the adjacent subarachnoid space and brain interstitial fluid (ISF) vi
259 e of the central nervous system involves the subarachnoid space and indicate that the leptomeninges p
261 (CRV), peripapillary choroid and sclera, and subarachnoid space around the optic nerve, were investig
262 omeningeal coverings of blood vessels in the subarachnoid space as potential access points allowing s
265 e small, dense fat droplets scattered in the subarachnoid space corresponding to a dermoid cyst ruptu
266 oduce Th1/Th17 cytokines, accumulated in the subarachnoid space early during the course of experiment
267 l processes that affect ventricular outflow, subarachnoid space function, or cerebral venous complian
269 therapeutic transgene, IL-10, to the spinal subarachnoid space have yielded promising results in ani
270 (90-100 microg/kg) was administered into the subarachnoid space in anesthetized cats 28-30 h before t
271 s included the difference in the size of the subarachnoid space in millimeters squared before and 1 h
274 l molecules can diffuse through the subdural/subarachnoid space into the underlying neocortex and spr
275 ngeal cells ensheathing blood vessels in the subarachnoid space may provide unique entry sites into t
277 ned-rank test was used to examine changes in subarachnoid space measurements (millimeters squared).
278 ne (90-100 mug/kg) was administered into the subarachnoid space of cats 30 h prior to EA or sham-oper
279 ecrosis factor and interferon gamma into the subarachnoid space of female Dark Agouti rats pre-immuni
280 hromaffin cells transplanted into the spinal subarachnoid space significantly reduced pain-related be
282 pressure induces forces in the retrolaminar subarachnoid space that can deform ONH structures, parti
283 inal fluid (CSF) barriers to spread into the subarachnoid space to induce dramatic viral meningoencep
284 skull base, with direct communication of the subarachnoid space to the extracranial space, usually a
285 jor histocompatibility class II+ APCs in the subarachnoid space were investigated using flow cytometr
286 CSF column extending extracranially from the subarachnoid space with or without brain/ meningeal hern
287 n lead to locally increased pressures in the subarachnoid space within the orbit, which impinges on t
288 med to be caused by elevated pressure in the subarachnoid space, does not correlate with the amount o
289 racerebral tissue (scalp, skull, dura mater, subarachnoid space, etc.) and the bottom layer (layer 2)
290 ized by excessive cerebrospinal fluid in the subarachnoid space, particularly over the frontal lobes.
299 reach the outer surface of the brain in the subarachnoid spaces from where it drains into venous blo
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。